Ghaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s

Published Date: 22 Dec 2024

Noaiseh discussed data from the DAHLIAS study linking, for the first time, clinical responses, with autoantibody levels.

Read Full News

Latest News

Lupus Can Cost Young Women More Years Than Diabetes, HIV

Lupus contributes substantially to premature mortality in young women, with over 304,000 years of potential life lost in women aged 15-44 years from 2000 to 2015.

Pulmonary Fibrosis Video Diaries: Patient Experiences and Timely Diagnosis of IPF

Pulmonary Fibrosis Video Diaries: Patient Experiences and Timely Diagnosis of IPF

From Evidence to Action: Practical Strategies for FcRn Therapy in gMG

From Evidence to Action: Practical Strategies for FcRn Therapy in gMG

Next-Gen Therapies for gMG: The Science and Support for FcRn Antagonists

Next-Gen Therapies for gMG: The Science and Support for FcRn Antagonists

Strategies for Personalized CIDP Care: Patient Selection, Treatment Transition, and FcRn Therapy

Strategies for Personalized CIDP Care: Patient Selection, Treatment Transition, and FcRn Therapy

Transforming CIDP Management: Early Diagnosis, Pathophysiology, and the Emerging Role of FcRn Antagonists

Transforming CIDP Management: Early Diagnosis, Pathophysiology, and the Emerging Role of FcRn Antagonists

Todays Updates

NP-Led Outreach Ups Cancer Screening in Rural Women Veterans

A nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.

Less Mental Decline With Darolutamide vs Enzalutamide in PC

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Todays Updates

NP-Led Outreach Ups Cancer Screening in Rural Women Veterans

A nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.

Less Mental Decline With Darolutamide vs Enzalutamide in PC

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Latest News

Lupus contributes substantially to premature mortality in young women, with over 304,000 years of potential life lost in women aged 15-44 years from 2000 to 2015.

Pulmonary Fibrosis Video Diaries: Patient Experiences and Timely Diagnosis of IPF

From Evidence to Action: Practical Strategies for FcRn Therapy in gMG

Next-Gen Therapies for gMG: The Science and Support for FcRn Antagonists

Strategies for Personalized CIDP Care: Patient Selection, Treatment Transition, and FcRn Therapy

Transforming CIDP Management: Early Diagnosis, Pathophysiology, and the Emerging Role of FcRn Antagonists

News All Time

Osteoarthritis: Promising Drug Therapy Flops

No help from diacerein in randomized trial

Another B-Cell Drug for Lupus Hits the Mark

Phase III results put obinutuzumab in line for approval

Europe Does Better Than U.S. in Treating Spondyloarthritis, Survey Data Suggest

American patients report more symptoms and mostly don't agree with doctors on how they've fared

Medicare Coverage Appears Spotty for Newer Rheumatoid Arthritis Meds

Advantage plans do a better job than standalone Part D policies, albeit with important gaps

ICE Chief Hospitalized; Metastatic Colon Cancer at Age 26; TENS for Fibromyalgia

Health news and commentary gathered by MedPage Today staff

Dyspnea in Woman With RA Reveals a Diaphragmatic Lipoma

MRI can help differentiate these benign soft-tissue masses from more aggressive liposarcomas

What Caused This Patient's Recurring Eye and Ear Inflammation?

Prompt diagnosis of this rare progressive autoimmune disease may help preserve hearing, eyesight

What Caused Left-Sided Hearing Loss in This 65-Year-Old Man?

Numerous diagnostic procedures revealed tophaceous gout affecting the middle ear

EULAR: Docs Should Push Hard on Physical Activity for Arthritis Patients

We have met the enemy and it's the sofa, updated guideline indicates

Rheumatic Disease Drugs Help COVID Virus Stick Around Longer, Study Suggests

Lengthy viral antigen persistence far more common, regardless of prior vaccination

Drug Targeting TLRs in Cutaneous Lupus Looks Good in Mid-Stage Studies

— Dose-response signal appears in phase II trial, and all doses are better than placebo

Upadacitinib After TNF Inhibitor Failure Improves RA Control

In patients with active RA, switching to upadacitinib after failure of a single TNF inhibitor is more effective in reducing disease activity at 12 weeks than using a second TNF inhibitor adalimumab.

Early Anti-TNF to Prevent Difficult-to-Treat RA Gains Steam

The availability of TNF inhibitor biosimilars and the cost of treating ‘difficult-to-treat’ RA are making first-line TNF inhibition in early RA more attractive in the UK.

FDA Grants Breakthrough Therapy Designation to Ianalumab, First Potential Sjögren’s Targeted Therapy Victoria Johnson

Novartis plans to submit regulatory applications for ianalumab in early 2026.

FDA Updates Label for Reduced Osteoarthritis Risk With BEAR Implant Over ACL Reconstruction Victoria Johnson

FDA approves a label update for the BEAR implant, which was previously approved in 2020.

FDA Grants Priority Review to Efgartigimod, First Potential Therapy for Seronegative Myasthenia Gravis Victoria Johnson

argenx's efgartigimod-alfa therapy was approved for seropositive generalized myasthenia gravis in 2021.

Recommended News For You

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.

Inner Thoughts of Leonard Bernstein, the "Maestro".

Recommended Articles For You

The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring 

Exosomes in Cancer: A Novel Frontier for Therapy and Biomarker Discovery 

Exploring the Latest Treatments for Essential Thrombocythemia 

Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

2.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness

3.

Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer

4.

According to a study, taking part in a clinical trial for cancer may not actually increase survival.

5.

A new blood test greatly increases the ability to detect cancer.

1.

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis

2.

Unraveling the Mysteries of Hematocrit: How It Impacts Your Health

3.

The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers

4.

Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer

5.

Surprising Symptoms of Prostate Cancer: What You Need to Know

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part X

2.

Efficient Management of First line ALK-rearranged NSCLC - Part III

3.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

4.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

5.

Updates on Standard V/S High Risk Myeloma Treatment- The Next Part

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot